Axsome Therapeutics to present at two major healthcare investor conferences in May 2026.

Axsome Therapeutics, a biopharmaceutical company focused on central nervous system disorders, announced its participation in two upcoming investor conferences in May 2026: the BofA Securities Health Care Conference on May 12 in Las Vegas and the RBC Capital Markets Global Healthcare Conference on May 19 in New York. The company will host fireside chats at both events and provide live webcasts accessible through its website, with replays available for 30 days. These presentations offer investors insights into Axsome's progress and future plans in developing treatments for neurological and psychiatric conditions affecting millions in the U.S.